“…Although inhibitors have been reported for JmjC-containing KDMs (Bavetsias et al., 2016, Gehling et al., 2016, Horton et al., 2016, Itoh et al., 2015, McAllister et al., 2016, Vinogradova et al., 2016, Westaway et al., 2016a, Westaway et al., 2016b, Wu et al., 2016), most of the published compounds have limitations such as lack of selectivity or cytotoxicity. Bavetsias et al.…”